SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Fundamental Analysis
USA - NYSE:SGFY - US82671G1004 - Common Stock
30.49 USD
+0.02 (+0.07%)
30.49 USD
0 (0%)
Taking everything into account, SGFY scores 4 out of 10 in our fundamental rating. SGFY was compared to 101 industry peers in the Health Care Providers & Services industry. While SGFY seems to be doing ok healthwise, there are quite some concerns on its profitability. SGFY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SGFY has reported negative net income.
In the past year SGFY had a positive cash flow from operations.
SGFY had negative earnings in 4 of the past 5 years.
SGFY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
SGFY has negative profitability rations, so we won't be analyzing them here.
Looking at the Return On Invested Capital, with a value of 6.14%, SGFY is in the better half of the industry, outperforming 67.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 6.14% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SGFY has a Operating Margin of 13.53%. This is amongst the best in the industry. SGFY outperforms 89.38% of its industry peers.
In the last couple of years the Operating Margin of SGFY has grown nicely.
With a decent Gross Margin value of 45.33%, SGFY is doing good in the industry, outperforming 72.57% of the companies in the same industry.
In the last couple of years the Gross Margin of SGFY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% |
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SGFY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SGFY has more shares outstanding
The debt/assets ratio for SGFY is higher compared to a year ago.
2.2 Solvency
SGFY has an Altman-Z score of 3.36. This indicates that SGFY is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, SGFY is in the better half of the industry, outperforming 76.99% of the companies in the same industry.
The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SGFY (93.50) is comparable to the rest of the industry.
SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
The Debt to Equity ratio of SGFY (0.53) is better than 60.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Altman-Z | 3.36 |
ROIC/WACC0.66
WACC9.37%
2.3 Liquidity
SGFY has a Current Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.62, SGFY is in the better half of the industry, outperforming 67.26% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.62, SGFY is in the better half of the industry, outperforming 72.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
The earnings per share for SGFY have decreased strongly by -390.91% in the last year.
The Revenue has grown by 23.33% in the past year. This is a very strong growth!
The Revenue has been growing by 17.09% on average over the past years. This is quite good.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
3.2 Future
SGFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 93.52% yearly.
Based on estimates for the next years, SGFY will show a quite strong growth in Revenue. The Revenue will grow by 18.33% on average per year.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
SGFY is valuated quite expensively with a Price/Forward Earnings ratio of 94.60.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SGFY is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.18. SGFY is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 |
4.2 Price Multiples
SGFY's Enterprise Value to EBITDA ratio is in line with the industry average.
SGFY's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1516.44 | ||
| EV/EBITDA | 32.74 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGFY's earnings are expected to grow with 93.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SGFY has a Yearly Dividend Yield of 1.26%. Purely for dividend investing, there may be better candidates out there.
SGFY's Dividend Yield is rather good when compared to the industry average which is at 2.41. SGFY pays more dividend than 85.84% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SGFY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
30.49
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 | ||
| P/S | 6.78 | ||
| P/FCF | 1516.44 | ||
| P/OCF | 171.13 | ||
| P/B | 8.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.74 |
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | 6.14% | ||
| ROICexc | 9.77% | ||
| ROICexgc | N/A | ||
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Debt/EBITDA | 2.07 | ||
| Cap/Depr | 52.6% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 3.36 |
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A